Antibodies to thyroid peroxidase (TPO-Ab), measured using sensitive and standardized immunoassays, are elevated in more than 95% of patients with HT and nearly 85% of patients with Graves’ disease (6, 7). The gene discussed is TPO; the disease is hematocrit.